These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 12696014)

  • 1. De novo infection in a renal transplant recipient caused by novel mutants of hepatitis B virus despite the presence of protective anti-hepatitis B surface antibody.
    Lu M; Lorentz T
    J Infect Dis; 2003 Apr; 187(8):1323-6. PubMed ID: 12696014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel hepatitis B virus variant S 129 (Gln-->Leu): lack of correlation between antigenicity and immunogenicity.
    Wu L; He JW; Yao X; Li HM; Wen YM
    J Med Virol; 1999 Dec; 59(4):424-30. PubMed ID: 10534722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new hepatitis B virus vaccine escape mutation in a renal transplant recipient.
    Sayiner AA; Agca H; Sengonul A; Celik A; Akarsu M
    J Clin Virol; 2007 Feb; 38(2):157-60. PubMed ID: 17210268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity.
    Kim KH; Ahn SH; Chung HY; Paik YH; Lee KS; Kim YS; Chon CY; Moon YM; Han KH
    J Gastroenterol Hepatol; 2004 Aug; 19(8):847-53. PubMed ID: 15242485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological significance of amino acid substitutions in hepatitis B surface antigen (HBsAg) for glycosylation, secretion, antigenicity and immunogenicity of HBsAg and hepatitis B virus replication.
    Wu C; Zhang X; Tian Y; Song J; Yang D; Roggendorf M; Lu M; Chen X
    J Gen Virol; 2010 Feb; 91(Pt 2):483-92. PubMed ID: 19812261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation of anti HBs monoclonal antibody and its combination characterization to both wild-type HBsAg and immune escape mutant HBsAg].
    Li FH; Zhang XY; Yan B; Zhang B; Huang YG; Zhang CY; Gong JS; Chen Y; Liu JH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jun; 24(6):594-6. PubMed ID: 18538091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of hepatitis B surface antibody to protect acute fulminating hepatitis in a renal transplant recipient.
    Sobhonslidsuk A; Sornmayura P; Sumethkul V
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S257-61. PubMed ID: 17044481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infections by hepatitis B surface antigen gene mutants in Europe and North America.
    Tabor E
    J Med Virol; 2006; 78 Suppl 1():S43-7. PubMed ID: 16622882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
    Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
    Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmission of "a" determinant variants of hepatitis B virus in immunized babies born to HBsAg carrier mothers.
    Velu V; Saravanan S; Nandakumar S; Dhevahi E; Shankar EM; Murugavel KG; Kumarasamy T; Thyagarajan SP
    Jpn J Infect Dis; 2008 Jan; 61(1):73-6. PubMed ID: 18219140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-HBs escape mutants--implication of neutralization escape and diagnostic escape].
    Okamoto H
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():98-105. PubMed ID: 15453295
    [No Abstract]   [Full Text] [Related]  

  • 13. Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient.
    Awerkiew S; Däumer M; Reiser M; Wend UC; Pfister H; Kaiser R; Willems WR; Gerlich WH
    J Clin Virol; 2007 Jan; 38(1):83-6. PubMed ID: 17134939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus.
    Ogata N; Cote PJ; Zanetti AR; Miller RH; Shapiro M; Gerin J; Purcell RH
    Hepatology; 1999 Sep; 30(3):779-86. PubMed ID: 10462386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen.
    Cooreman MP; Leroux-Roels G; Paulij WP
    J Biomed Sci; 2001; 8(3):237-47. PubMed ID: 11385295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A serological and molecular survey of hepatitis B in children 15 years after inception of the national hepatitis B vaccination program in eastern China.
    Dong Y; Liu SL; Zhai XJ; Zhu FC; Pan H; Yu JX; Chen YZ; Xie YR; Zhang XY; Zhang HM; Li LJ; Wang H; Ruan B
    J Med Virol; 2009 Sep; 81(9):1517-24. PubMed ID: 19626618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic hepatitis B virus (HBV) reactivation despite reduced viral fitness is associated with HBV test and immune escape mutations in an HIV-coinfected patient.
    Henke-Gendo C; Amini-Bavil-Olyaee S; Challapalli D; Trautwein C; Deppe H; Schulz TF; Heim A; Tacke F
    J Infect Dis; 2008 Dec; 198(11):1620-4. PubMed ID: 18847320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo acute hepatitis B infection in a previously vaccinated liver transplant recipient due to a strain of HBV with a Met 133 Thr mutation in the "a" determinant.
    Yoshida EM; Ramji A; Erb SR; Davis JE; Steinbrecher UP; Sherlock CH; Scudamore CH; Chung SW; Williams M; Gutfreund KS
    Liver; 2000 Oct; 20(5):411-4. PubMed ID: 11092260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reciprocal priming-boosting role of HBsAg and DNA vaccines].
    Zhou Z; Chen WS; Zhang HH; Yao JL
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):212-4. PubMed ID: 12716517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to G145R and other naturally occurring "a" loop escape mutations.
    Cooreman MP; van Roosmalen MH; te Morsche R; Sünnen CM; de Ven EM; Jansen JB; Tytgat GN; de Wit PL; Paulij WP
    Hepatology; 1999 Nov; 30(5):1287-92. PubMed ID: 10534351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.